HIV pill gets the go ahead from the FDA

On Monday, the US Food and Drug Administration approved Truvada, the first pill meant to lower the risk of contracting HIV in high-risk individuals.

According to the Associated Press, when taken as a preventative measure, the pill is able to reduce contraction by 42 percent in homosexual and bisexual men and by 75 percent in heterosexual couples when used with condoms.

Since 2004, the pill has been prescribed as a treatment for HIV-infected patients. However, in 2010, clinical trials found that the pill could be taken as a preventative measure.